Growth Metrics

Solid Biosciences (SLDB) Return on Assets (2018 - 2024)

Historic Return on Assets for Solid Biosciences (SLDB) over the last 7 years, with Q3 2024 value amounting to 0.47%.

  • Solid Biosciences' Return on Assets rose 1000.0% to 0.47% in Q3 2024 from the same period last year, while for Sep 2024 it was 0.47%, marking a year-over-year increase of 1000.0%. This contributed to the annual value of 0.46% for FY2023, which is 400.0% down from last year.
  • Per Solid Biosciences' latest filing, its Return on Assets stood at 0.47% for Q3 2024, which was up 1000.0% from 0.38% recorded in Q2 2024.
  • In the past 5 years, Solid Biosciences' Return on Assets ranged from a high of 0.08% in Q3 2021 and a low of 2.01% during Q3 2020
  • For the 5-year period, Solid Biosciences' Return on Assets averaged around 0.61%, with its median value being 0.44% (2023).
  • In the last 5 years, Solid Biosciences' Return on Assets crashed by -10600bps in 2020 and then skyrocketed by 19300bps in 2021.
  • Quarter analysis of 5 years shows Solid Biosciences' Return on Assets stood at 0.83% in 2020, then soared by 90bps to 0.08% in 2021, then tumbled by -325bps to 0.35% in 2022, then plummeted by -57bps to 0.56% in 2023, then rose by 16bps to 0.47% in 2024.
  • Its Return on Assets was 0.47% in Q3 2024, compared to 0.38% in Q2 2024 and 0.44% in Q1 2024.